Employees Provident Fund Board Acquires New Position in Synopsys, Inc. $SNPS

Employees Provident Fund Board acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 644,344 shares of the semiconductor company’s stock, valued at approximately $302,661,000. Synopsys accounts for approximately 2.2% of Employees Provident Fund Board’s portfolio, making the stock its 12th largest holding.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SNPS. Sankala Group LLC bought a new position in shares of Synopsys in the 4th quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the 4th quarter worth $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys during the 4th quarter worth $28,000. Atlas Capital Advisors Inc. acquired a new stake in Synopsys in the fourth quarter valued at about $32,000. Finally, Kemnay Advisory Services Inc. acquired a new stake in Synopsys in the fourth quarter valued at about $35,000. 85.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

SNPS has been the subject of several research analyst reports. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research note on Friday, February 20th. Stifel Nicolaus raised their price target on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Bank of America lifted their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Morgan Stanley upped their price objective on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research note on Wednesday, May 27th. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $563.81.

Check Out Our Latest Analysis on Synopsys

Insider Buying and Selling

In other news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $455.51 on Friday. The stock has a 50-day moving average price of $479.14 and a two-hundred day moving average price of $462.05. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The company has a market capitalization of $87.22 billion, a PE ratio of 105.44, a P/E/G ratio of 2.68 and a beta of 1.22. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the business posted $3.67 earnings per share. The business’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.